Petriti, Uarda
Dudman, Daniel C.
Scosyrev, Emil
Lopez-Leon, Sandra https://orcid.org/0000-0001-7504-3441
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 21 March 2022
Accepted: 29 December 2022
First Online: 16 January 2023
Declarations
:
: The manuscript does not contain clinical studies or patient data.
: Not applicable.
: <i>SLL</i> and <i>ES</i> are employees of Novartis Pharmaceutical Company; the statements presented in the paper do not necessarily represent the position of the company. <i>UP</i> is an employee of Cognizant Technology Solutions working on behalf of Novartis; the statements presented in the paper do not necessarily represent the position of either company. <i>DCD</i> is a former employee of Novartis Pharmaceutical Company and a former employee of Rutgers University Ernest Mario School of Pharmacy. <i>DCD</i> is a current employee of Seqirus.